LT recipients | 39 | 31 | |
Preoperative characteristics | | | |
Age years | 55±12 | 55±9 | 0.84 |
Females | 12 (31%) | 17 (55%) | 0.05 |
BMI kg·m−2 | 26±8 | 27±5 | 0.66 |
Aetiology | | | 0.07 |
Pulmonary fibrosis | 9 (23%) | 14 (45%) | |
COPD | 18 (46%) | 14 (45%) | |
Pulmonary hypertension | 2 (5%) | 2 (7%) | |
Cystic fibrosis | 6 (16%) | 0 (0%) | |
Others | 4 (10%) | 1 (3%) | |
Haemoglobin g·dL−1 | 14±2 | 14±2 | 0.88 |
Plasma protein level g·dL−1 | 7.4±0.7 | 7.3±0.7 | 0.44 |
Intraoperative characteristics | | | |
Procedure type: | | | |
Bilateral LT | 25 (64%) | 20 (65%) | 1.00 |
CPB use | 4 (10%) | 9 (29%) | 0.06 |
Blood product transfusion packs | 2 (4%) | 4 (6%) | 0.18 |
iNO use | 13 (33%) | 25 (81%) | <0.01 |
For hypoxaemia | 1 (8%) | 16 (64%) | 0.01 |
For PH | 11 (84%) | 19 (76%) | 0.26 |
Ischaemia time min | 299±76.0 | 332±64.8 | 0.05 |
Postoperative characteristics | | | |
ICU mortality | 0 (0%) | 5 (16%) | 0.02 |
Hospital mortality | 0 (0%) | 7 (23%) | <0.01 |
28-day mortality | 0 (0%) | 4 (13%) | 0.03 |
90-day mortality | 0 (0%) | 6 (19%) | <0.01 |
ICU LOS days | 22±23 | 32±15 | 0.04 |
MV length days | 16±22 | 28±18 | 0.02 |